MX387330B - Composiciones y metodos para el tratamiento de sindrome de intestino irritable - Google Patents
Composiciones y metodos para el tratamiento de sindrome de intestino irritableInfo
- Publication number
- MX387330B MX387330B MX2019001360A MX2019001360A MX387330B MX 387330 B MX387330 B MX 387330B MX 2019001360 A MX2019001360 A MX 2019001360A MX 2019001360 A MX2019001360 A MX 2019001360A MX 387330 B MX387330 B MX 387330B
- Authority
- MX
- Mexico
- Prior art keywords
- formula
- compositions
- treatment
- bowel syndrome
- irritable bowel
- Prior art date
Links
- 208000002551 irritable bowel syndrome Diseases 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 238000001990 intravenous administration Methods 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 239000006188 syrup Substances 0.000 abstract 1
- 235000020357 syrup Nutrition 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C15/00—Cyclic hydrocarbons containing only six-membered aromatic rings as cyclic parts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
- C07C229/54—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
- C07C229/60—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton with amino and carboxyl groups bound to carbon atoms of the same non-condensed six-membered aromatic ring with amino and carboxyl groups bound in meta- or para- positions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/45—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
- C07C233/53—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/55—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a carbon atom of an unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
- C07C229/14—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/12—Oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201641027529 | 2016-08-11 | ||
| PCT/IB2017/052233 WO2018029545A1 (en) | 2016-08-11 | 2017-04-19 | Compositions and methods for the treatment of irritable bowel syndrome |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019001360A MX2019001360A (es) | 2019-06-03 |
| MX387330B true MX387330B (es) | 2025-03-18 |
Family
ID=61163212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019001360A MX387330B (es) | 2016-08-11 | 2017-04-19 | Composiciones y metodos para el tratamiento de sindrome de intestino irritable |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11078154B2 (de) |
| EP (1) | EP3481383B1 (de) |
| JP (1) | JP2019524796A (de) |
| KR (1) | KR20190039723A (de) |
| CN (1) | CN109640965A (de) |
| AU (1) | AU2017308801B2 (de) |
| CA (1) | CA3031893A1 (de) |
| IL (1) | IL264467B (de) |
| MX (1) | MX387330B (de) |
| NZ (1) | NZ750126A (de) |
| RU (1) | RU2751770C2 (de) |
| SG (2) | SG10202101247QA (de) |
| WO (1) | WO2018029545A1 (de) |
| ZA (1) | ZA201900466B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3746451B1 (de) * | 2018-02-02 | 2023-07-12 | Boehringer Ingelheim International GmbH | Benzyl-, (pyridin-3-yl)methyl- oder (pyridin-4-yl)methyl-substituierte oxadiazolopyridinderivate als inhibitoren der ghrelin-o-acyl-transferase (goat) |
| CN113398112A (zh) * | 2021-06-17 | 2021-09-17 | 西南医科大学 | FA介导的BBA/CM-β-CD靶向递药系统、制备方法及其应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5080646A (en) | 1988-10-03 | 1992-01-14 | Alza Corporation | Membrane for electrotransport transdermal drug delivery |
| CN1044364C (zh) * | 1993-06-26 | 1999-07-28 | 河南师范大学 | 一种治疗肠炎和溃疡性结肠炎的药物及其制备工艺 |
| IL113459A (en) | 1995-04-23 | 2000-07-16 | Electromagnetic Bracing System | Electrophoretic cuff apparatus |
| US6239180B1 (en) | 1995-11-08 | 2001-05-29 | The Regents Of The University Of California | Transdermal therapeutic device and method with capsaicin and capsaicin analogs |
| EP0968711B9 (de) | 1997-10-28 | 2008-05-28 | Bando Chemical Industries, Ltd. | Dermatologisches pflaster und verfahren zur herstellung seiner basisschicht |
| US6103275A (en) | 1998-06-10 | 2000-08-15 | Nitric Oxide Solutions | Systems and methods for topical treatment with nitric oxide |
| DE19827732A1 (de) | 1998-06-22 | 1999-12-23 | Rottapharm Bv | Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie |
| US6312716B1 (en) | 1999-05-10 | 2001-11-06 | Peierce Management Llc | Patch and method for transdermal delivery of bupropion base |
| US6974588B1 (en) | 1999-12-07 | 2005-12-13 | Elan Pharma International Limited | Transdermal patch for delivering volatile liquid drugs |
| WO2006125293A1 (en) * | 2005-05-27 | 2006-11-30 | Antibe Therapeutics Inc. | Derivatives of 4- or 5-aminosalicylic acid |
| CN101365428B (zh) * | 2006-01-05 | 2012-08-29 | 威洛克塞斯药物股份公司 | 可负载崩解片剂 |
| KR101708065B1 (ko) * | 2008-07-08 | 2017-02-17 | 카타베이시스 파마슈티칼즈, 인코포레이티드 | 지방산 아세틸화 살리실레이트 및 그 용도 |
| AU2010234206B2 (en) * | 2009-04-06 | 2016-10-27 | Crearene Ag | Hemodialysis and peritoneal dialysis solutions comprising one or more creatine compounds |
| IT1400119B1 (it) * | 2010-05-24 | 2013-05-17 | Sofar Spa | Nuovi derivati della mesalazina, processo di sintesi ed uso nel trattamento di malattie infiammatorie intestinali. |
| WO2013175357A2 (en) * | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of inflammatory bowel disease |
| WO2014091384A2 (en) * | 2012-12-12 | 2014-06-19 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
| US9333187B1 (en) * | 2013-05-15 | 2016-05-10 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
-
2017
- 2017-04-19 US US16/323,069 patent/US11078154B2/en not_active Expired - Fee Related
- 2017-04-19 CN CN201780049248.9A patent/CN109640965A/zh active Pending
- 2017-04-19 AU AU2017308801A patent/AU2017308801B2/en not_active Ceased
- 2017-04-19 SG SG10202101247QA patent/SG10202101247QA/en unknown
- 2017-04-19 KR KR1020197005064A patent/KR20190039723A/ko not_active Ceased
- 2017-04-19 EP EP17838873.2A patent/EP3481383B1/de active Active
- 2017-04-19 NZ NZ750126A patent/NZ750126A/en not_active IP Right Cessation
- 2017-04-19 JP JP2019506688A patent/JP2019524796A/ja active Pending
- 2017-04-19 RU RU2019101849A patent/RU2751770C2/ru active
- 2017-04-19 MX MX2019001360A patent/MX387330B/es unknown
- 2017-04-19 WO PCT/IB2017/052233 patent/WO2018029545A1/en not_active Ceased
- 2017-04-19 SG SG11201900588YA patent/SG11201900588YA/en unknown
- 2017-04-19 CA CA3031893A patent/CA3031893A1/en active Pending
-
2019
- 2019-01-23 ZA ZA2019/00466A patent/ZA201900466B/en unknown
- 2019-01-24 IL IL264467A patent/IL264467B/en unknown
-
2021
- 2021-08-02 US US17/392,087 patent/US20220162156A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| MX2019001360A (es) | 2019-06-03 |
| RU2019101849A3 (de) | 2020-09-11 |
| EP3481383A1 (de) | 2019-05-15 |
| WO2018029545A1 (en) | 2018-02-15 |
| NZ750126A (en) | 2022-07-01 |
| CA3031893A1 (en) | 2018-02-15 |
| KR20190039723A (ko) | 2019-04-15 |
| US11078154B2 (en) | 2021-08-03 |
| JP2019524796A (ja) | 2019-09-05 |
| SG11201900588YA (en) | 2019-02-27 |
| US20220162156A1 (en) | 2022-05-26 |
| RU2019101849A (ru) | 2020-09-11 |
| AU2017308801B2 (en) | 2022-03-10 |
| EP3481383B1 (de) | 2023-06-14 |
| RU2751770C2 (ru) | 2021-07-16 |
| AU2017308801A1 (en) | 2019-02-07 |
| CN109640965A (zh) | 2019-04-16 |
| IL264467B (en) | 2021-09-30 |
| EP3481383A4 (de) | 2020-03-18 |
| US20190177267A1 (en) | 2019-06-13 |
| IL264467A (en) | 2019-02-28 |
| SG10202101247QA (en) | 2021-03-30 |
| ZA201900466B (en) | 2020-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX379545B (es) | Composiciones y metodos para el tratamiento del dolor cronico. | |
| MX386467B (es) | Composiciones y métodos para el tratamiento de xerostomia (sequedad bucal) | |
| WO2013175377A3 (en) | Compositions and methods for treatment of mucositis | |
| WO2013175376A3 (en) | Compositions and methods for the treatment of local pain | |
| NZ701832A (en) | Compositions and methods for treatment of inflammatory bowel disease | |
| MX2022005523A (es) | Composiciones y metodos para el tratamiento de infecciones fungicas. | |
| WO2016046680A3 (en) | Compositions and methods for the treatment of liver metabolic diseases | |
| WO2014091384A3 (en) | Compositions and methods for the treatment of mucositis | |
| WO2014068463A3 (en) | Compositions and methods for the treatment of inflammation and metabolic disorders | |
| MX2019001360A (es) | Composiciones y metodos para el tratamiento de sindrome de intestino irritable. | |
| MX384144B (es) | Composiciones y métodos para el tratamiento del cáncer. | |
| WO2013175359A3 (en) | Compositions and methods for the treatment of multiple sclerosis | |
| WO2020075023A3 (en) | Compositions and methods for the treatment of parkinson's disease | |
| WO2014087307A3 (en) | Compositions and methods for the treatment of metabolic syndrome and diabetes | |
| MX383090B (es) | Composiciones y métodos para el tratamiento de enfermedades infecciosas orales. | |
| WO2014087323A3 (en) | Compounds and compositions for the treatment of autoimmune and chronic metabolic diseases | |
| MX386208B (es) | Composiciones y métodos para el tratamiento de pólipos gastrointestinales. | |
| MX2015008661A (es) | Proceso para la obtencion de un derivado de fluorlactona. | |
| WO2015028976A3 (en) | Compounds and methods for the treatment of inflammatory diseases | |
| SG10201906474QA (en) | Compositions and methods for the treatment of mucositis | |
| MX2021000740A (es) | Composiciones y metodos para el tratamiento del cancer. | |
| WO2017208088A3 (en) | Compositions and methods for the treatment of parkinson's disease | |
| WO2014037834A3 (en) | Compositions and methods for treatment of inflammation and lipid disorders | |
| WO2014037833A3 (en) | Compositions and methods for treatment of inflammation and lipid disorders | |
| NZ736131A (en) | Compositions and methods for the treatment of epilepsy and neurological disorders |